Caprihans India share price, P/E, ROE & financials

As of 6 Nov 2026, Caprihans India is loss-making on a trailing 12-month basis, with a net loss of ₹11 Cr, so it has no P/E ratio. The share price is ₹98.65, 29% below its 52-week high. Sales fell 8.8% a year over 3 years. Debt is 1.58× equity. It is a small-cap company with a market cap of ₹144 Cr, ranked 137th of 204 Specialty Chemicals companies by market cap; the shares fell 16% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹98.65
Day high: ₹98.65
Day low: ₹98.65
Prev. close: ₹100.65
Volume: 25

Health check

6 to check

ReturnsBehind
−15.9% over a year, better than 0 of 7 peers.
Price tagLoss-making
Earnings were negative over the last 12 months.
GrowthShrinking
Sales −8.8% a year over 3 years.
ProfitabilityWeak
ROCE 2.3% vs peer median 24.4%.
Balance sheetStretched
Debt 1.58× equity, interest covered 0.5×.
Red flags4 to check
Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹144 Cr, #137 of 204 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹810 Cr · profit ₹−11 Cr

Market cap: ₹144 Cr; Small cap
P/E: n/a; Industry 22.1
Price to book: 0.41; Peers 13.33
Dividend yield: 0.00%
ROE: −2.6%; Peers 23.0%
ROCE: 2.3%; Peers 24.4%
Debt to equity: 1.58; Debt ₹671 Cr
EPS (TTM): −₹27.53
OPM (TTM): 8.8%; Net margin −1.3%
Sales growth: +22.7%; Latest quarter vs a year ago
Profit growth: n/a; Year-ago quarter not reported
Price to sales: 0.18; EV/EBITDA 10.8

Strengths

Quarterly sales up 22.7% on a year ago.

Risks to check

Loss-making over the last twelve months.
Return on equity is low at −2.6%.
Debt is 1.58× equity.
Interest coverage of only 0.5×.

Derived automatically from reported figures. Not a recommendation.

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax,…

Headquarters: Pune
Employees: 537
Sector: Basic Materials
ISIN: INE479A01018
Website: caprihansindia.com

Price range

52 weeks

₹50.30₹138.85

Today

₹98.65₹98.65

Avg volume (3M): 9.6K
1-year return: minus 15.9%
From 52-week high: minus 29.0%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
ASIANPAINTAsian Paints	2,546.00	plus 0.88%	2,44,025	50.5	35.0	24.4%	18.9%	0.21	1.1%	plus 1.5%
SOLARINDSSolar Industries India	18,608.00	plus 0.48%	1,68,384	74.4	64.1	29.5%	27.8%	0.22	12.4%	plus 35.9%
PIDILITINDPidilite Industries	1,579.00	plus 1.63%	1,60,827	60.0	44.4	28.5%	23.5%	0.03	7.4%	plus 6.8%
LINDEINDIALinde India	6,859.00	plus 8.73%	58,496	118.4	64.2	16.3%	31.5%	0.23	–	plus 5.4%
BERGEPAINTBerger Paints India	478.35	minus 5.28%	55,776	45.4	29.4	20.6%	15.3%	0.15	4.2%	minus 6.0%
FLUOROCHEMGujarat Fluorochemicals	4,665.50	minus 0.94%	51,251	75.9	44.0	9.6%	24.1%	0.26	−4.5%	plus 28.0%
ACUTAASAcutaas Chemicals	3,786.60	plus 0.42%	31,001	70.9	64.1	27.7%	39.4%	0.01	29.4%	plus 105.6%
CAPRIHANSCaprihans India	98.65	minus 1.99%	144	–	–	–	4.8%	1.58	–	minus 15.9%
Median of 7 peers	–	0.48%	58,496	70.9	44.4	24.4%	24.1%	0.21	5.8%	6.8%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
178	172	172	180	218
169	170	160	162	184
9.3	1.5	11.9	17.9	33.8
5.2%	0.9%	6.9%	10.0%	15.5%
3	4.4	3.1	18.4	1.8
19.1	19.6	17.6	18.3	18.7
10.9	11.6	11.3	11.1	10.8
–	–	−1.7	0.1	–
−17.7	−25.3	−15.6	7	6.2
23.2%	1.5%	−0.3%	–	–
−13.6	−24.9	−15.6	7	6.2
-9.27	-17.02	-10.67	3.93	-3.77

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: −8.8%
ROE: −2.6%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
924	695	738	702
–	minus 24.8%	+6.2%	minus 4.9%
859	651	703	662
65.3	44	35.1	39.4
7.1%	6.3%	4.8%	5.6%
3.3	15.7	14.5	25.2
56.8	80.5	80.8	71.8
33.3	43	42	42.6
127	−1.6	−6.1	−1.6
105	−65.3	−79.2	−51.5
31.9%	21.0%	20.9%	8.6%
71.8	−51.6	−62.7	−47
54.64	-39.31	-46.26	-32.08

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
199	199	160	158
155	104	126	101
630	747	668	615
438	368	306	310
1,421	1,417	1,261	1,185
1,016	968	891	857
1.1	5.8	5.8	9.4
77.7	7.7	10.7	14.2
8	27.3	5.6	0.8
318	408	348	304
1,421	1,417	1,261	1,185

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
–	−52.9	−46.7	107	121
–	−38	10.4	55	−8.2
–	89.5	37.2	−165	−118
–	−1.4	0.9	−3.2	−4.8
−3.4	–	−6.8	−8.7	−9.4
–	−52.9	−53.5	107	112
−0	−0	−0	−0.2	–

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you